Reported reasons for testing among hepatitis B virus-infected patients – Chronic Hepatitis Cohort Study (CHeCS), United States, 2006–2010

Authors

  • Gemechu B. Gerbi,

    1. Centers for Disease Control and Prevention, Atlanta, GA, USA
    Search for more papers by this author
  • Loralee B. Rupp,

    1. Henry Ford Health System, Detroit, MI, USA
    Search for more papers by this author
  • Stephen C. Ko,

    1. Centers for Disease Control and Prevention, Atlanta, GA, USA
    Search for more papers by this author
  • Anne C. Moorman,

    1. Centers for Disease Control and Prevention, Atlanta, GA, USA
    Search for more papers by this author
  • Scott D. Holmberg,

    1. Centers for Disease Control and Prevention, Atlanta, GA, USA
    Search for more papers by this author
  • Fujie Xu,

    1. Centers for Disease Control and Prevention, Atlanta, GA, USA
    Search for more papers by this author
  • and for the CHeCS Investigators

    Search for more papers by this author
    • The CHeCS Investigators include the following investigators and sites: Scott D. Holmberg, Eyasu H. Teshale, Philip R. Spradling, Anne C. Moorman, and Fujie Xu, Division of Viral Hepatitis, National Centers for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia; Stuart C. Gordon, David R. Nerenz, Mei Lu, Lois Lamerato, Loralee B. Rupp, Nonna Akkerman, Nancy J. Oja-Tebbe, Chad M. Cogan, and Dana Larkin, Henry Ford Health System, Detroit, Michigan; Joseph A. Boscarino, Zahra S. Daar, Robert E. Smith, Patrick J. Curry, Brandon D. Geise, and Joe B. Leader, Geisinger Health System, Danville, Pennsylvania; Cynthia C. Nakasato, Vinutha Vijayadeva, Kelly E. Sylva, John V. Parker, and Mark M. Schmidt, Kaiser Permanente, Honolulu, Hawaii; Emily M. Henkle, Tracy L. Dodge, Erin M. Keast, and Lois Drew, Kaiser Permanente Northwest, Portland, Oregon.

No abstract is available for this article.

Ancillary